---
schema_version: "secwatch.filing_event.v1"
accession: "0001552781-24-000138"
form_type: "8-K"
ticker: "SWKHL"
cik: "0001089907"
company_name: "SWK Holdings Corp"
filed_at: "2024-03-19T23:59:59+00:00"
generated_at: "2026-06-04T12:53:16.434181+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# SWK grants Aptar exclusive option to acquire Enteris GMP assets for ~$6M plus fee

## Summary
- Exclusive option to buy Enteris's GMP manufacturing and clinical supply assets; option expires Jan 1, 2026.
- Option fee low-single digit millions, payable in two installments; first fee due upon execution.
- Exercise price ~$6M plus inventory/prepaids; increases at high single digit CAGR if no exercise within 6 months.
- Aptar guarantees mid-single digit million minimum revenue for 2024-2025 under existing collaboration.
- If exercised, SWK retains excluded assets; transition services to be negotiated.

## SEC filing metadata
- accession: 0001552781-24-000138
- form_type: 8-K
- ticker: SWKHL
- cik: 0001089907
- company_name: SWK Holdings Corp
- filed_at: 2024-03-19T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1089907/000155278124000138/0001552781-24-000138-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1089907/000155278124000138/e24107_swkh-8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001552781-24-000138
- JSON: https://secwatch.observer/filing/0001552781-24-000138.json
- Plain text: https://secwatch.observer/filing/0001552781-24-000138.txt

## Key facts
- Material Agreements
  SWK Holdings Corp entered into Exclusive Option and Asset Purchase Agreement with AptarGroup, Inc. valued at low-single digit million dollar option fee (effective 2024-03-13).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: AptarGroup, Inc.
  - Value: low-single digit million dollar option fee
  - Effective: 2024-03-13
  source text: On March 13, 2024, Enteris Biopharma, Inc. (“Enteris”), a wholly owned subsidiary of SWK Holdings Corporation (“SWK”), and SWK entered into an exclusive option and asset purchase agreement (the “Exclusive Option and Asset Purchase Agreement”) with AptarGroup, Inc. (“Aptar”), pursuant to which Enteris granted to Aptar an exclusive option (the “Option”) to acquire certain of Enteris’s assets related to its business of providing good manufacturing practice (GMP) manufacturing and clinical supply services through Phase 1 and 2 to third parties (collectively, the “Assets”), subject to certain exclusions.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1089907/000155278124000138/0001552781-24-000138-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.